Preoperative Predictors for Organ‐Confined Disease in Japanese Patients with Stage T1c Prostate Cancer
Open Access
- 1 September 1998
- journal article
- research article
- Published by Wiley in International Journal of Urology
- Vol. 5 (5) , 454-458
- https://doi.org/10.1111/j.1442-2042.1998.tb00387.x
Abstract
Background: In order to define the characteristics of patients with clinical stage T1c prostate cancer in Japan, clinicopathologic data obtained from patients treated by radical prostatectomy were reviewed. Methods: Fifty‐four stage T1 c cancers were evaluated for tumor volume, Cleason grade, tumor location and pathologic stage from prostatectomy specimens in association with preoperative clinical parameters. Results: The mean tumor volume was 3.94 mL (range, 0.07 to 33.4 mL), and 11 of the 54 tumors had a tumor volume of less than 0.5 mL. Thirty‐two tumors (59%) were organ‐confined, while 7(13%) involved the seminal vesicle and/or regional lymph nodes. Multivariate logistic regression analysis of the pretreatment variables, including age, pretreatment PSA level, prostate volume, biopsy grade, and number of cancer‐positive cores revealed that the serum PSA level and the number of cancer‐positive biopsy cores were independent factors to predict organ‐confined tumors (P= 0.036 and 0.044, respectively). For T1c cancer with less than 4 cancer‐positive biopsy cores, the sensitivity and specificity for predicting organ‐confined tumors were 90% and 70%, with a cut‐off value of 17 ng/mL for the serum PSA level. Conclusion: The clinicopathologic features of Tic prostate cancer in Japanese patients were similar to those of whites reported elsewhere. Both serum PSA levels and the number of positive biopsy cores may be useful as pretreatment parameters to identify patients with the potential to benefit from radical treatment.Keywords
This publication has 28 references indexed in Scilit:
- Has There Been a Recent Shift in the Pathological Features and Prognosis of Patients Treated With Radical Prostatectomy?Journal of Urology, 1997
- Prospective Evaluation of Men With Stage T1C Adenocarcinoma of the ProstateJournal of Urology, 1997
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- An Algorithm for Predicting Nonorgan Confined Prostate Cancer Using the Results Obtained from Sextant Core Biopsies with Prostate Specific Antigen LevelJournal of Urology, 1996
- An Algorithm for Predicting Nonorgan Confined Prostate Cancer Using the Results Obtained from Sextant Core Biopsies with Prostate Specific Antigen LevelJournal of Urology, 1996
- Prospective characterization of pathological features of Prostatic Carcinomas Detected Via Serum Prostate Specific Antigen Based ScreeningJournal of Urology, 1996
- Prospective characterization of pathological features of Prostatic Carcinomas Detected Via Serum Prostate Specific Antigen Based ScreeningJournal of Urology, 1996
- Serum prostate‐specific antigen in a community‐based population of healthy Japanese men: lower values than for similarly aged white menBritish Journal of Urology, 1995
- Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screeningPublished by American Medical Association (AMA) ,1993
- Trends in Frequency of Latent Prostate Carcinoma in Japan from 1965-1979 to 1982-1986JNCI Journal of the National Cancer Institute, 1988